ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tribunal upholds CMA’s decision to fine Lexon ￡1.2m pharmatimes
March 02, 2021The Competition Appeal Tribunal (CAT) has maintained a decision made last year by the UK’s Competition and Markets Authority (CMA) to fine pharmaceutical firm Lexon ￡1.2m after finding the company guilty of breaking competition law. -
Two drug firms admit to colluding to keep prices up europeanpharmaceuticalreview
September 25, 2019King Pharmaceuticals Limited and Alissa Healthcare Research Limited have admitted to sharing information to keep drug prices up.
Pharma Sources Insight January 2025
